Pocock, Stuart J.

Polypill strategy in secondary cardiovascular prevention

Castellano, J. M., Pocock, S. J., Bhatt, D. L., Quesada, A. J., Owen, R., Fernandez-Ortiz, A., Sanchez, P. L., Marin Ortuño, F., Vazquez Rodriguez, J. M., Domingo-Fernández, A., et al. (2022) · New England Journal of Medicine

Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

Cited by 334

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 323

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Poulter, N. R., Wedel, H., Dahlöf, B., Sever, P. S., Beevers, D. G., Caulfield, M., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., et al. (2005) · The Lancet

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 319

Issues in the reporting of epidemiological studies: a survey of recent practice.

Pocock, S. J., Collier, T. J., Dandreo, K. J., de Stavola, B. L., Goldman, M. B., Kalish, L. A., Kasten, L. E., & McCormack, V. A. (2004) · BMJ

Statistical Methods in EpidemiologyMeta-analysis and systematic reviews

Cited by 313

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Butler, J., Packer, M., Filippatos, G., Ferreira, J. P., Zeller, C., Schnee, J., Brueckmann, M., Pocock, S. J., Zannad, F., & Anker, S. D. (2022) · European Heart Journal

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 264

Effects of Icosapent Ethyl on Total Ischemic Events

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 259

When to stop a clinical trial.

Pocock, S. J. (1992) · BMJ

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 255

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

Komajda, M., McMurray, J. J. V., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Pocock, S. J., Curtis, P. S., Jones, N. P., & Home, P. D. (2010) · European Heart Journal

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 234

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 231

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Rogers, J. K., Pocock, S. J., McMurray, J. J. V., Granger, C. B., Michelson, E. L., Östergren, J., Pfeffer, M. A., Solomon, S. D., Swedberg, K., & Yusuf, S. (2014) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 226

Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations

Rogers, J. K., McMurray, J. J. V., Pocock, S. J., Zannad, F., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., & Pitt, B. (2012) · Circulation

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 224

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

Guedeney, P., Giustino, G., Sorrentino, S., Claessen, B. E., Camaj, A., Kalkman, D. N., Vogel, B., Sartori, S., De Rosa, S., Baber, U., et al. (2022) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 208

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Butler, J., Filippatos, G., Jamal Siddiqi, T., Brueckmann, M., Böhm, M., Chopra, V. K., Pedro Ferreira, J., Januzzi, J. L., Kaul, S., Piña, I. L., et al. (2022) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 206

Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation

Pocock, S. J. (1997) · Controlled Clinical Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 184

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Butler, J., Anker, S. D., Filippatos, G., Khan, M. S., Ferreira, J. P., Pocock, S. J., Giannetti, N., Januzzi, J. L., Piña, I. L., Lam, C. S. P., et al. (2021) · European Heart Journal

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 183

Cardiovascular risk reduction with liraglutide: an exploratory mediation analysis of the LEADER trial

Buse, J. B., Bain, S. C., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Pratley, R. E., Linder, M., Monk Fries, T., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 175

Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort study

Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S. (2021) · The Lancet Healthy Longevity

Dementia and Cognitive Impairment ResearchLipoproteins and Cardiovascular Health

Cited by 161

Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations

Rogers, J. K., Jhund, P. S., Perez, A.-C., Böhm, M., Cleland, J. G., Gullestad, L., Kjekshus, J., van Veldhuisen, D. J., Wikstrand, J., Wedel, H., et al. (2014) · JACC: Heart Failure

Heart Failure Treatment and ManagementLipoproteins and Cardiovascular Health

Cited by 138

Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes

Filippatos, G., Butler, J., Farmakis, D., Zannad, F., Ofstad, A. P., Ferreira, J. P., Green, J. B., Rosenstock, J., Schnaidt, S., Brueckmann, M., et al. (2022) · Circulation

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 131

The agonising negative trend in monitoring of clinical trials

DeMets, D. L., Pocock, S. J., & Julian, D. G. (1999) · The Lancet

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 126

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

Kandzari, D. E., Townsend, R. R., Kario, K., Mahfoud, F., Weber, M. A., Schmieder, R. E., Pocock, S., Tsioufis, K., Konstantinidis, D., Choi, J., et al. (2023) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 124

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Gupta, A., Mackay, J., Whitehouse, A., Godec, T., Collier, T., Pocock, S., Poulter, N., & Sever, P. (2018) · The Lancet

Blood Pressure and Hypertension StudiesLipoproteins and Cardiovascular Health

Cited by 119

Comparison of time-to-first event and recurrent-event methods in randomized clinical trials

Claggett, B., Pocock, S., Wei, L. J., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D. (2018) · Circulation

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 118

Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation

Mahfoud, F., Townsend, R. R., Kandzari, D. E., Kario, K., Schmieder, R. E., Tsioufis, K., Pocock, S., David, S., Patel, K., Rao, A., et al. (2021) · Journal of the American College of Cardiology

Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Cited by 115